Building Telehealth Capacity for Cancer Co-Infections in Israel

GrantID: 9727

Grant Funding Amount Low: Open

Deadline: October 5, 2025

Grant Amount High: Open

Grant Application – Apply Here

Summary

If you are located in Israel and working in the area of Municipalities, this funding opportunity may be a good fit. For more relevant grant options that support your work and priorities, visit The Grant Portal and use the Search Grant tool to find opportunities.

Explore related grant categories to find additional funding opportunities aligned with this program:

Black, Indigenous, People of Color grants, Business & Commerce grants, Faith Based grants, Financial Assistance grants, Health & Medical grants, Higher Education grants.

Grant Overview

Israel's Unique Position in Cancer Research

Israel is distinguished by its robust healthcare infrastructure and innovative research capabilities, making it an ideal location for investigations into co-infection and cancer. The country's Ministry of Health, particularly its Department of Research and Development, plays a significant role in promoting and supporting cancer research initiatives. Israel's unique blend of academic excellence, technological advancement, and a high standard of healthcare positions it favorably for this funding opportunity.

One of the key geographic features that distinguishes Israel is its diverse population density, ranging from densely populated urban areas like Tel Aviv to more sparsely populated regions in the Negev Desert. This demographic diversity presents an opportunity to study cancer incidence and co-infection patterns across different population groups. Furthermore, Israel's experience in managing complex healthcare challenges, such as during the COVID-19 pandemic, has honed its capabilities in epidemiological research and data analysis, which can be leveraged for studying the interplay between co-infections and cancer.

Leveraging Israel's Strengths for Cancer Investigations

Israel's strengths in biomedical research and its history of producing cutting-edge medical technologies provide a fertile ground for the proposed investigations. The Israel Cancer Association, a non-profit organization, works closely with the Ministry of Health and other stakeholders to support cancer research and patient support initiatives. This collaborative environment is conducive to the kind of mechanistic and epidemiologic investigations that this funding aims to support. Moreover, Israel's integration into global health research networks facilitates the sharing of knowledge and best practices, potentially enriching the outcomes of the research conducted under this grant.

The country's research institutions, such as the Weizmann Institute of Science and the Technion - Israel Institute of Technology, are renowned for their excellence in biomedical sciences. These institutions have the potential to contribute significantly to understanding the complex interactions between co-infections and cancer. Israel's unique geopolitical position also allows for comparative studies with neighboring regions, offering insights into how different environmental and healthcare system factors influence cancer incidence and outcomes.

Aligning with Global and Local Health Priorities

The focus of this funding on co-infection and cancer aligns with global health priorities, as well as specific health concerns in Israel. Given the country's demographic characteristics and its experience with various infectious diseases, research in this area can have both local and international relevance. By supporting investigations into the mechanisms and epidemiology of co-infection and cancer, this funding can contribute to enhancing healthcare outcomes not just in Israel but also in other regions facing similar health challenges.

The research funded by this grant can inform public health policies and clinical practices, potentially leading to better management and treatment of cancer cases complicated by co-infections. As Israel continues to face health challenges that require innovative solutions, the insights gained from this research can be instrumental in shaping its healthcare response and contributing to the global body of knowledge on cancer and co-infections.

Q: How does Israel's diverse population impact cancer research? A: Israel's diverse population allows researchers to study cancer incidence and co-infection patterns across different demographic groups, providing valuable insights into how various factors influence cancer outcomes.

Q: What role do Israeli research institutions play in cancer investigations? A: Institutions like the Weizmann Institute of Science and the Technion - Israel Institute of Technology are at the forefront of biomedical research, contributing significantly to the understanding of complex interactions between co-infections and cancer.

Q: How can research funded by this grant benefit Israel's healthcare system? A: The research can inform public health policies and clinical practices, potentially leading to better management and treatment of cancer cases complicated by co-infections, thereby enhancing healthcare outcomes in Israel.

Eligible Regions

Interests

Eligible Requirements

Grant Portal - Building Telehealth Capacity for Cancer Co-Infections in Israel 9727

Related Grants

Grant to Advance Animal Advocacy through Intellectual and Artistic Expression

Deadline :

2099-01-31

Funding Amount:

Open

The Foundation funds academic and artistic projects that raise public awareness about animal rights. Grants are awarded in three categories: Research...

TGP Grant ID:

10016

Nonprofit Grant to Help Jewish Youth, Women and the Elderly

Deadline :

Ongoing

Funding Amount:

Open

This grant is designed to support local community-based initiatives with a focus on specific population groups such as youth, women and girls, older a...

TGP Grant ID:

10068

Nonprofit Grant To Support Jewish People

Deadline :

2099-12-31

Funding Amount:

Open

 The Foundation Grant requests can be for programs, general support, or a capital project. The following are the areas of primary interest of the...

TGP Grant ID:

10250